Join to View Full Profile
201 Gibraltar RdSte 120Horsham, PA 19044
Phone+1 215-706-2034
Fax+1 215-706-4176
Dr. Potz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1982 - 1985
Tufts University School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1993 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013, 2015-2017
Clinical Trials
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) Start of enrollment: 2021 May 14
Publications & Presentations
PubMed
- 10 citationsMetastatic prostatic adenocarcinoma within a primary solid papillary carcinoma of the male breast.Sunati Sahoo, Roberta E. Smith, Joseph L. Potz, Paul Peter Rosen
Archives of Pathology & Laboratory Medicine. 2001-08-01 - 47 citationsEngraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34 + cell contentC H Weaver, J Potz, J. Redmond, Tauer Kw, Lee S. Schwartzberg
Bone Marrow Transplantation. 1997-06-01 - 60 citationsCis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.Andrew Dayton, Ernest Terwilliger, Potz J, Mark Kowalski, Joseph Sodroski
Journal of Acquired Immune Deficiency Syndromes. 1988-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
